Literature DB >> 17003045

Regulation of the ring finger E3 ligase Siah2 by p38 MAPK.

Ashwani Khurana1, Koh Nakayama, Scott Williams, Roger J Davis, Tomas Mustelin, Ze'ev Ronai.   

Abstract

The RING finger ubiquitin ligase Siah2 controls the stability of various substrates involved in stress and hypoxia responses, including the PHD3, which controls the stability of HIF-1alpha. In the present study we determined the role of Siah2 phosphorylation in the regulation of its activity toward PHD3. We show that Siah2 is subject to phosphorylation by p38 MAPK, which increases Siah2-mediated degradation of PHD3. Consistent with these findings, MKK3/MKK6 double-deficient cells, which cannot activate p38 kinases, exhibit impaired Siah2-dependent degradation of PHD3. Phosphopeptide mapping identified T24 and S29 as the primary phospho-acceptor sites. Phospho-mutant forms of Siah2 (S29A or T24A/S29A) exhibit impaired degradation of PHD3, particularly after hypoxia. Conversely, a phospho-mimic form of Siah2 (T24E/S29D) exhibits stronger degradation of PHD3, compared with wild type Siah2. Whereas phospho-mutant Siah2 exhibits weaker association with PHD3, phospho-mimic Siah2 associates as well as wild type and is localized within the perinuclear region, suggesting that phosphorylation of Siah2 affects its subcellular localization and, consequently, the degree of its association with PHD3. In all, our findings reveal the phosphorylation of Siah2 by p38 and the implications of such phosphorylation for Siah2 activity toward PHD3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003045      PMCID: PMC2954258          DOI: 10.1074/jbc.M606568200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

Authors:  S I Matsuzawa; J C Reed
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

Review 2.  RING finger proteins: mediators of ubiquitin ligase activity.

Authors:  C A Joazeiro; A M Weissman
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

Review 3.  Molecular recognitions in the MAP kinase cascades.

Authors:  Takuji Tanoue; Eisuke Nishida
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

4.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

Review 5.  The ubiquitin-proteasome pathway: on protein death and cell life.

Authors:  A Ciechanover
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

6.  Stress-induced decrease in TRAF2 stability is mediated by Siah2.

Authors:  Hasem Habelhah; Ian J Frew; Aaron Laine; Peter W Janes; Frederic Relaix; David Sassoon; David D L Bowtell; Ze'ev Ronai
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

7.  Regulation of BOB.1/OBF.1 stability by SIAH.

Authors:  J Boehm; Y He; A Greiner; L Staudt; T Wirth
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

8.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

9.  Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.

Authors:  Babak Shemirani; David L Crowe
Journal:  Oral Oncol       Date:  2002-04       Impact factor: 5.337

10.  Mechanism of p38 MAP kinase activation in vivo.

Authors:  Deborah Brancho; Nobuyuki Tanaka; Anja Jaeschke; Juan-Jose Ventura; Nyaya Kelkar; Yoshinori Tanaka; Masanao Kyuuma; Toshikazu Takeshita; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

View more
  39 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

Review 2.  Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.

Authors:  Mainak Guharoy; Pallab Bhowmick; Peter Tompa
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

3.  Lotus japonicus E3 ligase SEVEN IN ABSENTIA4 destabilizes the symbiosis receptor-like kinase SYMRK and negatively regulates rhizobial infection.

Authors:  Griet Den Herder; Satoko Yoshida; Meritxell Antolín-Llovera; Martina K Ried; Martin Parniske
Journal:  Plant Cell       Date:  2012-04-24       Impact factor: 11.277

Review 4.  The ubiquitin ligase Siah2 and the hypoxia response.

Authors:  Koh Nakayama; Jianfei Qi; Ze'ev Ronai
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

5.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

6.  Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Authors:  Tapasree Roy Sarkar; Shikha Sharan; Jun Wang; Snehalata A Pawar; Carrie A Cantwell; Peter F Johnson; Deborah K Morrison; Ju-Ming Wang; Esta Sterneck
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

7.  USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains.

Authors:  Marzia Scortegagna; Tony Subtil; Jianfei Qi; Hyungsoo Kim; Wenhui Zhao; Wei Gu; Harriet Kluger; Ze'ev A Ronai
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

8.  Inhibition of Siah ubiquitin ligase function.

Authors:  A Möller; C M House; C S F Wong; D B Scanlon; M C P Liu; Z Ronai; D D L Bowtell
Journal:  Oncogene       Date:  2008-10-13       Impact factor: 9.867

Review 9.  Regulators and effectors of Siah ubiquitin ligases.

Authors:  Jianfei Qi; Hyungsoo Kim; Marzia Scortegagna; Ze'ev A Ronai
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

10.  SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.

Authors:  M Buchwald; K Pietschmann; P Brand; A Günther; N P Mahajan; T Heinzel; O H Krämer
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.